.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
UBS
McKesson
Express Scripts
Chinese Patent Office
Citi
Argus Health
US Army
Cantor Fitzgerald
QuintilesIMS

Generated: September 23, 2017

DrugPatentWatch Database Preview

ACYCLOVIR Drug Profile

« Back to Dashboard

Which patents cover Acyclovir, and what generic Acyclovir alternatives are available?

Acyclovir is a drug marketed by Watson Labs, Amneal Pharms, Actavis Elizabeth, Apotex Inc, Glenmark Pharms Ltd, Mylan Pharms Inc, Zydus Pharms Usa Inc, Teva Pharms, Abbvie, Hi Tech Pharma, Mylan, Teva, Dava Pharms Inc, Fougera Pharms Inc, Chartwell Molecules, Hetero Labs Ltd V, Ivax Sub Teva Pharms, Tolmar, Actavis Mid Atlantic, Cadila Pharms Ltd, Lek Pharm, Carlsbad Technology, Taro, Roxane, Ranbaxy, Sun Pharm Inds Ltd, Carlsbad, Heritage Pharms Inc, Boscogen, Eurohlth Intl Sarl, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Parenteral, Hikma Pharms, Athenex Inc, and Apothecon. and is included in sixty NDAs.

The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-five drug master file entries for this compound. Seven suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the acyclovir sodium profile page.

Summary for Tradename: ACYCLOVIR

Patents:0
Applicants:38
NDAs:60
Suppliers / Packagers: see list61
Bulk Api Vendors: see list112
Clinical Trials: see list96
Patent Applications: see list7,621
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ACYCLOVIR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION203927-001Mar 29, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Cadila Pharms Ltd
ACYCLOVIR
acyclovir
TABLET;ORAL202168-002Nov 15, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Lek Pharm
ACYCLOVIR
acyclovir
CAPSULE;ORAL074750-001Apr 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074897-002Feb 27, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
ACYCLOVIR
acyclovir
TABLET;ORAL074976-001Apr 13, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms Inc
ACYCLOVIR
acyclovir
TABLET;ORAL074891-001Oct 31, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
ACYCLOVIR
acyclovir
TABLET;ORAL074870-002Jun 5, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
ACYCLOVIR
acyclovir
TABLET;ORAL074976-002Apr 13, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
ACYCLOVIR
acyclovir
TABLET;ORAL074980-002Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms Inc
ACYCLOVIR
acyclovir
TABLET;ORAL074891-002Oct 31, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Novartis
Federal Trade Commission
Deloitte
Citi
Baxter
McKesson
Colorcon
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot